Dr. Banno Pins Down Subtle STEMI Case Using PMcardio’s OMI AI Model
This case highlighted the limitations of traditional diagnostic methods and led Dr. Banno to explore innovative solutions for cardiac care. This exploration introduced him to the PMcardio tool, an AI-powered clinical decision support system for ECG interpretation
This case highlighted the limitations of traditional diagnostic methods and led Dr. Banno to explore innovative solutions for cardiac care. This exploration introduced him to the PMcardio tool, an AI-powered clinical decision support system for ECG interpretation.
“One case that significantly impacted my clinical approach involved a 56-year-old man who presented with acute chest pain to the emergency room. The patient had risk factors, including hypertension and a history of smoking. Initial evaluations showed no ST elevations on the ECG, but his troponin levels were markedly elevated.“
PMcardio OMI AI Model indicated a high probability of Occlusion Myocardial Infarction (OMI).
“Running the patient’s ECG through the PMcardio tool indicated a high probability of Occlusion Myocardial Infarction (OMI), which reinforced my clinical suspicion and prompted an immediate intervention. PMcardio alleviates many challenges in diagnosing OMI by providing high-confidence interpretations that can support clinical judgment. This tool not only reduces diagnostic uncertainty but also enhances the accuracy of cardiac assessments.“
Angiographically confirmed Occlusive Myocardial Infarction (OMI).
“I would recommend the tool to other healthcare professionals. Its ability to learn from large datasets and provide reliable diagnostics far surpasses traditional criteria-based systems. PMcardio has the potential to revolutionize cardiac care, facilitating early and accurate intervention for OMI cases.“
Armed with the tool, Dr. Banno integrates AI-driven insights into his ECG assessments, advocating for its broader adoption to optimize cardiac care and improve patient outcomes.
Share this article
About PMcardio
PMcardio is a CE-marked Class IIb AI medical device that interprets any 12-lead ECG — from a photo or a digital file — in seconds. It detects 50+ ECG findings, including occlusion myocardial infarction (OMI) — the acute coronary occlusions that conventional STEMI criteria miss in over half of cases. Its Queen of Hearts™ OMI model holds FDA Breakthrough Device Designation, and PMcardio is already used by 100,000+ clinicians who have analyzed more than 2.5 million ECGs.
About Powerful Medical
Powerful Medical is a medical-technology company using artificial intelligence to transform how cardiovascular disease — the world’s leading cause of death — is diagnosed. Founded in 2017, it built PMcardio, the world’s first AI medical device to detect acute coronary occlusion (OMI) from an ECG. Its research is published in the European Heart Journal – Digital Health and validated across 25+ clinical studies, and its Queen of Hearts™ model earned FDA Breakthrough Device Designation. To date, PMcardio has supported the detection of 120,000+ heart attacks across 150+ hospital deployments worldwide.
